Skip to content

Abbott ABT Total Liabilities

Total Liabilities at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$2.94B+3.2%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$116.09B+1.0%
Artivion logo
ArtivionAORT
$62.32M+24.5%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$1.09B+5.1%
Boston Scientific logo
Boston ScientificBSX
$1.58B
DexCom logo
DexComDXCM
$3.83B-19.4%

Other financials

Income statement

See full
Revenue$12.6B+13.0%
Gross profit$7.3B+15.6%
Operating income$1.7B-17.5%
Net income$928.0M-47.8%
EPS (diluted)$0.53-47.5%

Balance sheet

See full
Cash & equivalents$5.1B-26.6%
Total debt$32.6B+143%
Total equity$51.1B+1.1%
Total assets$109.22B+30.0%

Cash flow

See full
Operating cash flow$2.5B+21.5%
CapEx$497.0M-1.0%
Free cash flow$2.0B+28.9%

Valuation

See full
Market cap$186.84B-16.1%
Enterprise value$214.35B-6.5%
P/E34.4×+18.5×
P/S-1.2×

Profitability

See full
Gross margin56.6%+0.6pp
Operating margin15.8%-1.7pp
Net margin11.6%-20.8pp
FCF margin16.8%+1.1pp

Returns & leverage

See full
Return on equity10.7%-20.4pp
Debt / equity0.6×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesFairValueDisclosure.

The official record: Abbott’s 10-Q, filed July 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Abbott's total liabilities?
Abbott (ABT) reported total liabilities of $4.61B in Q2 2026.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.